Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3755 USD | -1.16% | -5.49% | -14.64% |
06-05 | Transcript : AIM ImmunoTech Inc. - Special Call | |
05-16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 |
Sales 2024 * | 128K 176K | Sales 2025 * | 1.78M 2.44M | Capitalization | 21.45M 29.37M |
---|---|---|---|---|---|
Net income 2024 * | -24M -32.86M | Net income 2025 * | -25M -34.23M | EV / Sales 2024 * | 167 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.1 x |
P/E ratio 2024 * |
-0.77
x | P/E ratio 2025 * |
-0.83
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.99% |
Latest transcript on AIM ImmunoTech Inc.
1 day | -1.16% | ||
1 week | -5.49% | ||
Current month | +3.73% | ||
1 month | -2.47% | ||
3 months | -14.46% | ||
6 months | -25.63% | ||
Current year | -14.64% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 22-04-03 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy Bryan
BRD | Director/Board Member | 66 | 23-03-27 |
William Mitchell
CHM | Chairman | 89 | 98-06-30 |
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-26 | 0.3755 | -1.16% | 341,915 |
24-06-25 | 0.3799 | -2.84% | 261,952 |
24-06-24 | 0.391 | -4.73% | 128,141 |
24-06-21 | 0.4104 | +4.29% | 321,100 |
24-06-20 | 0.3935 | -0.96% | 200,155 |
Delayed Quote Nyse, June 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.64% | 21.45M | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.13% | 26.64B | |
-21.81% | 19.91B | |
-16.77% | 16.32B | |
-44.74% | 15.52B | |
-18.81% | 15.49B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- AIM Stock